Gregory M Weinhoff

Chief Business Officer

Gregory M Weinhoff (Chief Business Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Centessa Pharmaceuticals plc (CNTA). The largest single filing was $1.9M of CNTA (73,196 sh across 2 lots, as filed), executed Mar 13.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 2 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.6M

shares × price, as filed

Last traded

Mar 26

Filed Mar 26

Median ADV $76.8M across their filed names

Open performance→

Volume by month

Buys $0 Sells $4.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names

CNTA Centessa Pharmaceuticals plc CNTA · 0 buys · 13 sells 13 filings

Recent filings

CNTASALE Centessa Pharmaceuticals plc View filing → $193K
11,742 sh × $16.47
Exec Jan 27 2025
Filed Jan 28 2025 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $170K
10,000 sh × $17.04
Exec Dec 26 2024
Filed Dec 26 2024 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $177K
10,000 sh × $17.66
Exec Nov 25 2024
Filed Nov 27 2024 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $181K
11,742 sh × $15.38
Exec Oct 25 2024
Filed Oct 25 2024 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $261K
16,619 sh × $15.69
Exec Sep 25 2024
Filed Sep 27 2024 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $510K
30,000 sh × $17.00
Exec Sep 10 2024
Filed Sep 12 2024 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $375K
25,000 sh × $15.00
Exec Sep 9 2024
Filed Sep 9 2024 · 5:30 PM ET